Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Pasithea Therapeutics Corp. KTTA: This clinical-stage biotechnology company has seen the Zacks Consensus Estimate for its current-year earnings increasing 59.1% over the last 60 days.
Pasithea Therapeutics Corp. Price and Consensus
Pasithea Therapeutics Corp. price-consensus-chart | Pasithea Therapeutics Corp. Quote
Northern Trust Corporation NTRS: This financial holding company has seen the Zacks Consensus Estimate for its current year earnings increasing 5.7% over the last 60 days.
Northern Trust Corporation Price and Consensus
Northern Trust Corporation price-consensus-chart | Northern Trust Corporation Quote
Yext, Inc. YEXT: This consumer information platform company has seen the Zacks Consensus Estimate for its current year earnings increasing 21.4% over the last 60 days.
Yext Price and Consensus
Yext price-consensus-chart | Yext Quote
Aehr Test Systems, Inc. AEHR: This semiconductor testing solutions company has seen the Zacks Consensus Estimate for its current year earnings increasing 337.5% over the last 60 days.
Aehr Test Systems Price and Consensus
Aehr Test Systems price-consensus-chart | Aehr Test Systems Quote
State Street CorporationSTT: This financial services company has seen the Zacks Consensus Estimate for its current year earnings increasing 8.1% over the last 60 days.
State Street Corporation Price and Consensus
State Street Corporation price-consensus-chart | State Street Corporation Quote
You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
State Street Corporation (STT) : Free Stock Analysis Report
Northern Trust Corporation (NTRS) : Free Stock Analysis Report
Aehr Test Systems (AEHR) : Free Stock Analysis Report
Yext (YEXT) : Free Stock Analysis Report
Pasithea Therapeutics Corp. (KTTA) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
